Skip to main content

Many Dead Patients Still Listed as Alive in Electronic Health Records

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 31, 2023.

By Lori Solomon HealthDay Reporter

FRIDAY, Dec. 29, 2023 -- Nearly one in five deceased patients are marked alive in electronic health records (EHRs) and 80 percent received primary care outreach after their death, according to a research letter published online Dec. 4 in JAMA Internal Medicine.

Neil S. Wenger, M.D., from the University of California, Los Angeles, and colleagues investigated what proportion of active patients a health system is unaware are deceased. The analysis included EHR data from 11,698 seriously ill, continuity primary care patients (aged 18 years and older with two or more primary care visits during the prior year) seen at 41 clinics across an academic health system.

The researchers found that 25 percent of included patients were recorded as deceased in the EHR, while 5.8 percent were deceased according to the state death files but marked alive in the EHR. Eighty percent of the 676 patients not known to be deceased had an encounter or appointment outstanding after death and received an estimated 221 telephone calls and 338 portal messages. Furthermore, 221 of these patients received 920 letters concerning unmet preventive care needs (e.g., flu shots, cancer screening), 166 patients received 226 other mailed correspondence, 158 patients had 184 orders placed for vaccines and other clinical care, and 88 medications were authorized in 130 encounters.

"Better awareness of vital status is needed for health systems to provide accountable care," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted December 2023

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.